NCT00000576View on ClinicalTrials.gov

Inhaled Beclomethasone to Prevent Chronic Lung Disease

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 1993

Study Completion Date

April 30, 1999

Conditions

Bronchopulmonary DysplasiaHyaline Membrane DiseaseLung Diseases

Interventions

DRUG

beclomethasone

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH